Takahiro Yamanaka

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Venues

Cancer science

This page only lists publications with an associated author ORCID identifier.

Publications

Takahiro Yamanaka, Kenichiro Araki, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Dolgormaa Gantumur, Norihiro Ishii, Mariko Tsukagoshi, Akira Watanabe, Norifumi Harimoto, Atsushi Masamune, Haruki Uojima, Masashi Mizokami, Kiyoaki Ito, Ken Shirabe
Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer. Cancer science 115 (4) (2024)
Takahiro Yamanaka, Kenichiro Araki, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Dolgormaa Gantumur, Norihiro Ishii, Mariko Tsukagoshi, Akira Watanabe, Norifumi Harimoto, Atsushi Masamune, Haruki Uojima, Masashi Mizokami, Kiyoaki Ito, Ken Shirabe
Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer. Cancer science (2024)
Takahiro Yamanaka, Kenichiro Araki, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Dolgormaa Gantumur, Norihiro Ishii, Mariko Tsukagoshi, Akira Watanabe, Norifumi Harimoto, Atsushi Masamune, Haruki Uojima, Masashi Mizokami, Kiyoaki Ito, Ken Shirabe
Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer. Cancer science 115 (4) (2024)
Takahiro Yamanaka, Kenichiro Araki, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Dolgormaa Gantumur, Norihiro Ishii, Mariko Tsukagoshi, Akira Watanabe, Norifumi Harimoto, Atsushi Masamune, Haruki Uojima, Masashi Mizokami, Kiyoaki Ito, Ken Shirabe
Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer. Cancer science 115 (4) (2024)
Takahiro Yamanaka, Kenichiro Araki, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Dolgormaa Gantumur, Norihiro Ishii, Mariko Tsukagoshi, Akira Watanabe, Norifumi Harimoto, Atsushi Masamune, Haruki Uojima, Masashi Mizokami, Kiyoaki Ito, Ken Shirabe
Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer. Cancer science 115 (4) (2024)
Takahiro Yamanaka, Kenichiro Araki, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Dolgormaa Gantumur, Norihiro Ishii, Mariko Tsukagoshi, Akira Watanabe, Norifumi Harimoto, Atsushi Masamune, Haruki Uojima, Masashi Mizokami, Kiyoaki Ito, Ken Shirabe
Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer. Cancer science 115 (4) (2024)
Ryo Muranushi, Kenichiro Araki, Takehiko Yokobori, Batbayar Chingunjav, Kouki Hoshino, Gantumur Dolgormaa, Kei Hagiwara, Takahiro Yamanaka, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Akira Watanabe, Norio Kubo, Norifumi Harimoto, Yuki Shimoda, Rie Sano, Tetsunari Oyama, Hiroshi Saeki, Ken Shirabe
High membrane expression of CMTM6 in hepatocellular carcinoma is associated with tumor recurrence. Cancer science 112 (8) (2021)

Takahiro Yamanaka.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Takahiro Yamanaka